FDA OKs New Adult Insomnia Med
The approval was based on a phase 3 trial showing daridorexant was associated with improved sleep onset, sleep maintenance, and daytime functioning in adults with insomnia.
Source: medscape.com
Stay updated with breaking news from Primary Insomnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval was based on a phase 3 trial showing daridorexant was associated with improved sleep onset, sleep maintenance, and daytime functioning in adults with insomnia.